Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice.
Many studies have demonstrated that prostate stem cell antigen (PSCA) is an attractive target for immunotherapy based on its overexpression in prostate tumor tissue, especially in some metastatic tissues. In this study, we evaluated dendritic cell (DC)-directed lentiviral vector (DCLV) encoding muri...
Main Authors: | Liang Xiao, Kye-Il Joo, Matthew Lim, Pin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3490948?pdf=render |
Similar Items
-
Transitory response to vaccination with PSCA-/PSA-peptide loaded, autologous dendritic cells in patients with metastatic, hormone-refractory prostate cancer
by: Waller CF, et al.
Published: (2004-07-01) -
Direct Lymph Node Vaccination of Lentivector/Prostate-Specific Antigen is Safe and Generates Tissue-Specific Responses in Rhesus Macaques
by: Bryan C. Au, et al.
Published: (2016-02-01) -
The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
by: Qian Xiang, et al.
Published: (2020-01-01) -
Armierung von NK-Zellen mit den PSCA-spezifischen chimären Antigenrezeptoren NKp46-αPSCA und NKp46-KiBAP-αPSCA
by: Michen, Susanne
Published: (2015) -
Impact of PSCA variation on gastric ulcer susceptibility.
by: Chizu Tanikawa, et al.
Published: (2013-01-01)